Summary
Basal levels of glucocorticoids maintained by negative feedback regulation are known to modulate a wide range of physiological processes, through a variety of effects such as those on carbohydrate metabolism and “permissive” actions on effects of other hormones. Glucocorticoid levels increase sharply in response to the stress of any kind of threat to homeostasis. The increased levels have traditionally been ascribed the function of enhancing the organism’s resistance to stress. How known physiological and pharmacological effects of high levels of glucocorticoids might accomplish this function, however, has been a mystery.
A generalization that is beginning to emerge is that many of these effects may be secondary to modulation by glucocorticoids of the actions of numerous intercellular mediators, including established hormones, prostanoids, neutral proteinases, and cytokines such as interferon. These mediators participate in physiological mechanisms — endocrine, renal, immune, neural, etc. — that mount a first line of defense against such challenges to homeostasis as hemorrhage, metabolic disturbances, infection, anxiety, and others.
Contrary to the traditional view that the role of glucocorticoids in stress is to enhance these defense mechanisms, it has become increasingly clear that glucocorticoids at moderate to high levels generally suppress them. This paradox first emerged when glucocorticoids were discovered to be antiinflammatory agents, and had remained a major obstacle to a unified picture of glucocorticoid function.
We have suggested that stress-induced increases in glucocorticoid levels protect not against the source of stress itself but rather against the body’s normal reactions to stress, preventing those reactions from overshooting and themselves threatening homeostasis. This hypothesis, the seeds of which are to be found in many earlier discussions of glucocorticoid effects, immediately accounts for the paradox noted above, and provides glucocorticoid physiology with a unified conceptual framework that can accommodate such apparently unrelated physiological and pharmacological effects as those on carbohydrate metabolism, inflammatory processes, shock and water balance. It also leads us to propose that some enzymes rapidly induced by glucocorticoids detoxify mediators released during stress-induced activation of primary defense mechanisms; those mediators could themselves cause damage if left unchecked.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- FcR:
-
Fc-receptor
- IFN-γ:
-
immune interferon, γ-interferon
- MAF:
-
macrophage activating factor
- FRAF:
-
Fc-receptor augmenting factor
- IL-1:
-
interleukin 1, LAF, lymphocyte activating factor, EP, endogenous pyrogen, MCF, mononuclear cell factor
- IL-2:
-
interleukin 2
- CSF:
-
colony stimulating factor
- CRF:
-
corticotropin releasing factor
- ACTH:
-
adrenocorticotropin, corticotrophin
- ADH:
-
antidiuretic hormone, vasopressin
- POMC:
-
proopiomelanocortin
- 5HT:
-
serotonin, 5-hydroxytryptamine
- IgG:
-
immunoglobulin G
- dexamethasone:
-
9α-fluoro-l6α-methyl-11β,17α, 21-trihydroxypregna-1,4-diene-3,20-dione.
References
A. Munck P. M. Guyre, N. J. Holbrook, Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev. 5: 25 (1984).
J. Axelrod, T. D. Reisine, Stress hormones: their interaction and regulation. Science 22. 4: 452 (1984).
A. del Rey, H. Besedovsky, E. Sorkin, Endogenous blood levels of corticosterone control the immunologic cell mass and B cell activity in mice. J. Immunol. 133: 572 (1984).
W. Aberer, L. Stingl, S. Pogantsch, G. Stingl, Effect of glucocorticosteroids on epidermal cell-induced immune responses. J. Immunol. 133: 792 (1984).
A. Kelso, A. Munck, Glucocorticoid inhibition of lymphokine secretion by alloreactive T-lymphocyte clones. J. Immunol. 133: 784 (1984).
P. M. Guyre, J. E. Bodwell, A. Munck, Glucocorticoid actions on lymphoid tissue and the immune system: physiologic and therapeutic implications. In: Gurpide E, Calandra R, Levy C, Soto RJ (eds) Hormones and Cancer. Alan R. Liss, New York, p. 181 (1984).
L. Shen, P. M. Guyre, M. W. Fanger, Direct stimulation of ADCC by cloned gamma interferon is not ablated by glucocorticoids: studies using a human monocyte-like cell line (U937). Mol. Immunol. 21: 167 (1984).
S. K. Arya, F. Wong-Staal, R. C. Gallo, Dexamethasone-mediated inhibition of human T cell growth factor and Y-interferon messenger RNA. J. Immunol. 133: 273.
G. H. Reem, N. H. Yeh, Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T-lymphocytes. Science 225: 429 (1984).
T. Hattori, F. Hirata, T. Hoffman, A. Hizuta, R. B. Herberman, Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein. J. Immunol. 131: 662 (1983).
B. Rothhut, F. Russo-Marie, J. Wood, M. DiRosa, R. J. Flower, Further characterization of the glucocorticoid-induced antiphospholipase protein “renocortin.” Biochem. Biophys. Res. Comm. 117: 878 (1983).
A. Naray-Fejes-Toth, G. Fejes-Toth, C. Fischer, J. C. Frolich, Effect of dexamethasone on in vivo prostanoid production in the rabbit. J. Clin. Invest. 74; 120 (1984).
G. Barseghian, C. Tomkinson, D. L. Hwang, A. Lev-Ran, Effect of corticosterone on carbamylcholine-, leucine-, or calcium-induced insulin secretion by the isolated perfused pancreas. Endocrinology 114: 1086 (1984).
S. E. Keller, J. M. Weiss, N. E. Miller, M. Stein, Stress-induced suppression of immunity in adrenalectomized rats. Science 221: 1301 (1983).
P. M. Guyre, J. E. Bodwell, A. Munck, Glucocorticoid actions on the immune system: inhibition of production of an Fcreceptor augmenting factor. J. Steroid Biochem. 15: 35 (1981).
M. Tausk, Hat die Nebenniere tatsachlich eine Verteidigungsfunktion? Das Hormon (Organon, Holland) 3: 1 (1951).
H. Selye, Stress in Health and Disease. Butterworths, London, pp 30, 31 (1976).
J. Le, J. Vilcek, Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-y. Cell Immunol. 85: 278 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Munck, A., Guyre, P.M. (1986). Glucocorticoid Physiology, Pharmacology and Stress. In: Chrousos, G.P., Loriaux, D.L., Lipsett, M.B. (eds) Steroid Hormone Resistance. Advances in Experimental Medicine and Biology, vol 196. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5101-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5101-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5103-0
Online ISBN: 978-1-4684-5101-6
eBook Packages: Springer Book Archive